Inventor · disambiguated record

Christopher Loren Wahl

Also filed as: Wahl Christopher Loren

23 granted patents·29 pending applications·40 citations·filing 2017–2024

93Inventor score

Technology areasA61K A61M A61B C07K C12Q

Files withPROGENITY INC29 BIORA THERAPEUTICS INC23

Top patents by PatentIndex Score

52 records

0192US10610104B2Gastrointestinal tract detection methods, devices and systemsPROGENITY INC·Filed 2017·Granted Apr 7, 2020·7 cites·22 claims
0291US11439802B2Ingestible device for delivery of therapeutic agent to the gastrointestinal tractBIORA THERAPEUTICS INC·Filed 2021·Granted Sep 13, 2022·5 cites·24 claims
0391US11007356B2Ingestible device for delivery of therapeutic agent to the gastrointestinal tractPROGENITY INC·Filed 2020·Granted May 18, 2021·3 cites·39 claims
0489US10588608B2Sampling systems and related materials and methodsPROGENITY INC·Filed 2017·Granted Mar 17, 2020·11 cites·33 claims
0588US11857669B2Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devicesBIORA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·1 cites·18 claims
0687US2025000364A1Gastrointestinal tract detection methods, devices and systemsBIORA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
0786US11523772B2Treatment of a disease of the gastrointestinal tract with an immunosuppressantBIORA THERAPEUTICS INC·Filed 2017·Granted Dec 13, 2022·6 cites·20 claims
0883US11033490B2Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devicesPROGENITY INC·Filed 2017·Granted Jun 15, 2021·3 cites·18 claims
0983US2025082265A1Treatment of a disease of the gastrointestinal tract with an immunosuppressantBIORA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
1080US12150775B2Treatment of a disease of the gastrointestinal tract with an immunosuppressantBIORA THERAPEUTICS INC·Filed 2022·Granted Nov 26, 2024·0 cites·20 claims
1178US12171764B2Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitorBIORA THERAPEUTICS INC·Filed 2019·Granted Dec 24, 2024·1 cites·19 claims
1278US11596670B2Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonistBIORA THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·2 cites·27 claims
1378US2024252425A1Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devicesBIORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
1474US11597762B2Treatment of a disease of the gastrointestinal tract with an IL-12/IL-23 inhibitor released using an ingestible deviceBIORA THERAPEUTICS INC·Filed 2017·Granted Mar 7, 2023·1 cites·20 claims
1573US11547301B2Methods for collecting and testing bacteria containing samples from within the gastrointestinal tractPROGENITY INC·Filed 2021·Granted Jan 10, 2023·0 cites·39 claims
1672US12089916B2Gastrointestinal tract detection methods, devices and systemsBIORA THERAPEUTICS INC·Filed 2020·Granted Sep 17, 2024·0 cites·17 claims
1771US11938295B2Ingestible device for delivery of therapeutic agent to the gastrointestinal tractBIORA THERAPEUTICS INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
1871US2024335644A1Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible deviceBIORA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
1971US2024252795A1Ingestible device for delivery of therapeutic agent to the gastrointestinal tractBIORA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
2071US2022249814A1Methods and devices for treating a disease with biotherapeuticsPROGENITY INC·Filed 2019·Application pending·0 cites
2169US2025230229A1Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible deviceBIORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2269US2023363663A1Electromechanical ingestible device for delivery of a dispensable substanceBIORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2366US2023019619A1Treatment of a disease of the gastrointestinal tract with a tlr modulatorBIORA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
2465US11918342B2Localization systems and methods for an ingestible deviceBIORA THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·0 cites·23 claims
2564US11707610B2Ingestible device for delivery of therapeutic agent to the gastrointestinal tractBIORA THERAPEUTICS INC·Filed 2020·Granted Jul 25, 2023·0 cites·19 claims
2663US2020170627A1Sampling systems and related materials and methodsPROGENITY INC·Filed 2020·Application pending·0 cites
2761US2023023414A1Methods and devices for treating a disease with biotherapeuticsPROGENITY INC·Filed 2019·Application pending·0 cites
2860US11793420B2Ingestible device for delivery of a dispensable substanceBIORA THERAPEUTICS INC·Filed 2020·Granted Oct 24, 2023·0 cites·10 claims
2959US11363964B2Localization systems and methods for an ingestible devicePROGENITY INC·Filed 2018·Granted Jun 21, 2022·0 cites·31 claims
3059US2022071894A1Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitorPROGENITY INC·Filed 2021·Application pending·0 cites
3158US10980739B2Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitorPROGENITY INC·Filed 2017·Granted Apr 20, 2021·0 cites·16 claims
3256US12227565B2Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestineBIORA THERAPEUTICS INC·Filed 2019·Granted Feb 18, 2025·0 cites·15 claims
3356US2025195855A1Ingestible device for delivery of therapeutic agent to the gastrointestinal tractBIORA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3453US11426566B2Treatment of a disease of the gastrointestinal tract with a TLR modulatorBIORA THERAPEUTICS INC·Filed 2017·Granted Aug 30, 2022·0 cites·18 claims
3553US2021138213A1Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible devicePROGENITY INC·Filed 2018·Application pending·0 cites
3650US2018070857A1Electromechanical ingestible device for delivery of a dispensable substancePROGENITY INC·Filed 2017·Application pending·0 cites
3748US2023041197A1Treatment of a disease of the gastrointestinal tract with an immunomodulatorPROGENITY INC·Filed 2019·Application pending·0 cites
3847US2022135666A1Treatment of a disease of the gastrointestinal tract with a s1p modulatorPROGENITY INC·Filed 2018·Application pending·0 cites
3947US2020253506A1Treatment of a disease of the gastrointestinal tract with an integrin inhibitorPROGENITY INC·Filed 2017·Application pending·0 cites
4047US2021401895A1Treatment of a disease of the gastrointestinal tract with live biotherapeuticsPROGENITY INC·Filed 2018·Application pending·0 cites
4146US2021386367A1Devices and systems for gastrointestinal microbiome detection and manipulationPROGENITY INC·Filed 2019·Application pending·0 cites
4245US2020094031A1Treatment of a disease of the gastrointestinal tract with a chst15 inhibitorPROGENITY INC·Filed 2018·Application pending·0 cites
4344US11134889B2Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitorPROGENITY INC·Filed 2017·Granted Oct 5, 2021·0 cites·23 claims
4444US2023312700A1Treatment of a disease of the gastrointestinal tract with a tnf inhibitorPROGENITY INC·Filed 2019·Application pending·0 cites
4544US2021363233A1Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitorPROGENITY INC·Filed 2019·Application pending·0 cites
4644US2020323772A1Treatment of inflammatory disease using ingestible device to release immune modulatorPROGENITY INC·Filed 2018·Application pending·0 cites
4743US11471134B2Ingestible device recovery systemPROGENITY INC·Filed 2017·Granted Oct 18, 2022·0 cites·16 claims
4843US2020306516A1Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereofPROGENITY INC·Filed 2018·Application pending·0 cites
4943US2019343425A1Treatment of a disease of the gastrointestinal tract with a tnf inhibitorPROGENITY INC·Filed 2017·Application pending·0 cites
5042US2020315540A1Treatment of a disease of the gastrointestinal tract with an il-1 inhibitorPROGENITY INC·Filed 2017·Application pending·0 cites

Showing the top 50 of 52 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Christopher Loren Wahl files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →